Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
involves analyzing a tumor's genetic, genomic, and molecular characteristics to tailor personalized treatment strategies. By identifying specific mutations, gene expressions, and molecular signatures, this approach helps predict which therapies are most likely to be effective for individual patients. Molecular profiling can enhance precision medicine by targeting treatments based on a patient's unique cancer profile rather than a one-size-fits-all approach.